BioCentury
ARTICLE | Clinical News

Ampligen rintatolimod regulatory update

July 23, 2012 7:00 AM UTC

Hemispherx submitted an NDA to Argentina's National Administration of Drugs, Foods and Medical Technology (ANMAT) for Ampligen to treat chronic fatigue syndrome (CFS). The company is also requesting O...